Drug maintenance treatment;Medicamenteuze onderhoudsbehandeling

Tijdschrift voor Kindergeneeskunde

Volumn 77, Issue 6, 2009, Pages 243-249

  Rottier, Bart L ^a   Brouwer, M L ^b   Janssens, H M ^c   Thio, B J ^d   Hendriks, J J E ^e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

^e VieCuri   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; MEDICAL RESEARCH; PHENOTYPE; SMOKING;

EID: 76149090865     PISSN: 03767442     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086404     Document Type: Article

References (22)

1. Global Strategy for Asthma Management and Prevention 2006. www.gina.com.
2. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. A national clinical guideline. 2005.
3. Duiverman EJ. Richtlijn 'Astmabehandeling bij kinderen' van kinderlongartsen (2e herziening). II. Medicamenteuze behandeling. Ned Tijdschr Geneeskd. 2003:147:2501.
4. National Heart LaBI, National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung and Blood Institute, 2007.
5. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006:354:1998-2005.
6. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354: 1985-97.
7. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054-63.
8. Janssens HM, Jongste JC de, Hop WC, Tiddens HA. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest. 2003;123:2083-8.
9. Devadason SG, Huang T, Walker S, et al. Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children. Eur Respir J. 2003;21:1007-11.
10. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J. 1998:12:1346-53.
11. Roller CM, Zhang G, Troedson RG, et al. Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children. Eur Respir J. 2007; 29:299-306.
12. Molimard M, Martinat Y, Rogeaux Y, et al. Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. Respir Med. 2005;99:770-8.
13. Horiguchi T, Hayashi N, Ohira D, et al. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone. J Asthma. 2006;43:509-12.
14. Goldin JG, Tashkin DP, Kleerup EC, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol. 1999;104:5258-67.
15. Sin D, Man J, Sharpe H, et al. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. JAMA. 2004;292:367-76.
16. Jat GC, Mathew JL, Singh M. Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. Ann Allergy Asthma Immunol. 2006;97:397-401.
17. Verini M, Peroni DG, Piacentini GL, et al. Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures. Allergy Asthma Proc. 2007;28:691-4.
18. Taylor DR. The beta-agonist saga and its clinical relevance: on and on it goes. Am J Respir Crit Care Med. 2009;179:976-8.
19. Versteegh FGA. De kinderlongverpleegkundige. In: Jongste JC de, Vrijlandt EJLE. Astma bij kinderen, samenvatting van de herziene richtlijnen van de SKL. Utrecht: NVK, Sectie Kinderlongziekten, 2008. pp. 83-9.
20. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Ann Intern Med. 1999:130:487-95.
21. Bracken M, Fleming L, Hall P, et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child. 2009;94:780-4.
22. Groot H de, Brand PL, Fokkens WF, Berger MY. Allergic rhinoconjunctivitis in children. BMJ. 2007;335:985-8.